AstraZeneca

Tetraphase Pharmaceuticals: A Small Cap With Big Potential
Seeking Alpha
Sat, 01/4/14 - 04:14 pm
Tetraphase Pharmaceuticals
AstraZeneca
Cubist Pharmaceuticals
antiobiotics
Eravacycline
JNJ
Merck
Pfizer
AstraZeneca buys a CDK9 cancer drug portfolio
Fierce Biotech
Fri, 01/3/14 - 01:36 pm
AstraZeneca
CDK9
cancer
Probiodrug
Grading Pharma In 2013: 16 Drug Companies Ranked
Forbes
Tue, 12/31/13 - 10:17 am
Bristol-Myers Squibb
Celgene
Gilead Sciences
Biogen Idec
AbbVie
Roche
JNJ
GSK
Amgen
Novo Nordisk
Pfizer
Novartis
Merck
Sanofi
AstraZeneca
Eli Lilly
AstraZeneca and Shionogi extend Crestor license
Reuters
Fri, 12/27/13 - 09:42 am
Crestor
AstraZeneca
Shionogi
How Will AstraZeneca Plc Fare In 2014?
Motley Fool, UK
Fri, 12/27/13 - 09:37 am
AstraZeneca
Is AstraZeneca plc Set For Electrifying Earnings Growth In 2014?
Motley Fool, UK
Tue, 12/24/13 - 09:48 am
AstraZeneca
Bristol-Myers sale of diabetes franchise positive, says BMO Capital
The Fly on the Wall
Mon, 12/23/13 - 11:12 am
diabetes
M&A
Bristol-Myers Squibb
AstraZeneca
Hanmi does not infringe AstraZeneca's Nexium -U.S. appeals court
Reuters
Fri, 12/20/13 - 08:47 am
patents
Hanmi Pharma
Nexium
AstraZeneca
Biotech Stocks: A Year in Review
Yahoo/TheStreet.com
Fri, 12/20/13 - 08:34 am
Amgen
Teva
Forest Labs
AstraZeneca
Medivation
JNJ
AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
Yahoo/Reuters
Thu, 12/19/13 - 08:12 am
Bristol-Myers Squibb
diabetes
AstraZeneca
AstraZeneca’s Arimidex Halves Breast Cancer Risk, Study Finds
Bloomberg
Tue, 12/17/13 - 08:57 am
Arimidex
AstraZeneca
breast cancer
[video]The Biggest Victims of the Patent Cliff in 2014
Motley Fool
Mon, 12/16/13 - 08:11 am
patents
AstraZeneca
Eli Lilly
Cymbalta
Nexium
Bristol, AstraZeneca withdraw diabetes drug in Germany, the day after it was endorsed by an FDA panel
Yahoo/Reuters
Fri, 12/13/13 - 10:43 am
Germany
diabetes
AstraZeneca
Dapagliflozin
Bristol-Myers Squibb
FDA panel throws dirt on Bristol-Myers' orphan drug metreleptin
Fierce Biotech
Thu, 12/12/13 - 04:15 pm
FDA
advisory panels
Bristol-Myers Squibb
metreleptin
AstraZeneca
partial lipodystrophy
Keep an Eye on AstraZeneca, Avanir, Bristol-Myers Squibb and VIVUS Today
Motley Fool
Thu, 12/12/13 - 11:12 am
AstraZeneca
Avair
Bristol-Myers Squibb
Vivus
metreleptin
Nuedexta
Avanafil
Sanofi
Stomach acid drugs may increase vitamin deficiency risk
Reuters
Wed, 12/11/13 - 12:11 pm
PPIs
H2RAs
Prevacid
Prilosec
Nexium
Tagamet
Zantac
GSK
Boehringer Ingelheim
P&G
AstraZeneca
Takeda
FDA staff cautious on AstraZeneca, Bristol diabetes drug
Yahoo/Reuters
Tue, 12/10/13 - 09:21 am
FDA
AstraZeneca
Bristol-Myers Squibb
Dapagliflozin
diabetes
AstraZeneca is first to win EU approval for an inhaled 4-in-1 flu vaccine
Fierce Pharma
Fri, 12/6/13 - 11:57 am
vaccines
Europe
Flu
flu vaccines
AstraZeneca
Fluenz Tetra
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy
Seeking Alpha
Thu, 12/5/13 - 06:43 pm
Pfizer
GSK
melanoma
Bristol-Myers Squibb
AstraZeneca
Daiichi Sankyo
Novartis
Yervoy
palbociclib
Mekinist
Zelboraf
AstraZeneca Eyes Forest Labs as Shares Rise
Motley Fool
Thu, 12/5/13 - 08:28 am
Forest Labs
AstraZeneca
M&A

Pages